On May 4, 2020, the U.S. Patent and Trademark Office (USPTO) unveiled a new web-based intellectual property marketplace…
On Apr. 30, 2020, Mesoblast announced a Phase 2/3 randomized, placebo-controlled trial to rigorously confirm whether its allogeneic…
On Apr. 28, 2020, Entos Pharmaceuticals announced a collaboration with EpiVax. This partnership combined the Entos Fusogenix DNA…
On Apr. 27, 2020, Regeneron and Sanofi announced the primary endpoint of overall survival was met in a…
On Apr. 24, 2020, Mesoblast announced an 83% survival in ventilator-dependent COVID-19 patients (10/12) with moderate/severe acute respiratory…
On Apr. 23, 2020, Emergent BioSolutions announced an agreement whereby Emergent will deploy its contract development and manufacturing…
On Apr. 22, 2020, Cocrystal Pharma announced it has expanded its previously announced license agreement with Kansas State…
On Apr. 21, 2020, BioSig Technologies announced that subsidiary ViralClear Pharmaceuticals, had submitted an application for Vicromax(tm) (merimepodib,…
On Apr. 8, 2020, Chugai Pharma announced that it is working to start a phase III clinical trial…
On Mar. 26, 2020, Amneal Pharma announced it had donated 1,000,000 hydroxychloroquine sulfate tablets to the Texas State…
On Mar. 17, 2020, Innovation Pharma announced details on the Material Transfer Agreement signed with a leading public…
On Mar. 13, 2020, Enanta Pharmaceuticals announced it had initiated a program to discover direct-acting antiviral drug candidates…
On Feb. 21, 2020, Lundbeck announced that VYEPTI™ (eptinezumab-jjmr) had been approved by the U.S. Food and Drug…
On Feb. 4, 2020, BioMotiv and Bristol-Myers Squibb announced the launch of Anteros Pharmaceuticals, a biotechnology company focused…
On Jan. 28, 2020, Alexion Pharma announced it had completed its acquisition of Achillion Pharmaceuticals for $930 million….
On Nov. 22, 2019, the Centers for Disease Control and Prevention”s (CDC) Advisory Committee on Immunization Practices (ACIP)…
On Nov. 12, 2019, Calporta Therapeutics, one of eight San Diego biotech companies Avalon Ventures created with GlaxoSmithKline,…
On Oct. 22, 2019, Lundbeck, located in Valby, Denmark, announced it had completed its acquisition of Bothell, Washington-based…
On Sept. 15, 2019, Purdue Pharma filed for Chapter 11 bankruptcy and announced that it had reached an…
On Aug. 15, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it was awarded…
On Jul. 18, 2019, Chembio Diagnostics announced a collaboration with Shire Human Genetic Therapies, a wholly owned subsidiary…
On May 30, 2019, FUJIFILM opened a Life Science Strategic Business Office in Cambridge, Massachusetts to create a…
On Jan. 23, 2019, U.S. Food and Drug Administration (FDA) announced it had approved approved the use of…
On Jan. 9, 2019, AstraZeneca announced it had closed plants in Colorado and layed off 210 workers. AstraZeneca…
On Jan. 8, 2019, Takeda Pharmaceutical announced the completion of its acquisition of Lexington, Massachusetts-based Shire for a…
On Oct. 16, 2018, Discovery Life Sciences expanded by merging with Conversant Bio, Folio Bio, and Phylogeny to…
On Aug. 9, 2018, Arizona Life Science Genealogy was published illustrating life science companies and non-profit research organization…
On Jul. 6, 2018, Teva Pharmaceuticals announced it would move its U.S. headquarters to Parsippany-Troy Hills, New Jersey…
Texas Life Science Genealogy illustrates life science companies and non-profit research organization in the State of Texas by…
On Mar. 8, 2018, Sanofi acquired Waltham, Massachusetts-based Bioverativ for for $11.6 billion. Bioverativ’s extended half-life therapies, Eloctate…